We are excited to announce that the Contract Award Notice ‘Results of the procurement procedure’ of the Instand-NGS4P Request for Tender has today been published in the Official Journal of the European Union supplement (OJ/S) and is available on the TED database under 2022/S 095-263180.
The tenderers who have successfully concluded Framework Agreements and Specific Contracts for Phase 1 – Solution Design are:
Lot 1: (Consortium Lead)
Agilent Technologies R&D Marketing GmbH & Co KG
Integrated DNA Technologies, BV
QIAGEN GmbH
Thermo Fisher Scientific Life Technologies GmbH
Twist Bioscience Corporation
Lot 3: (Consortium Lead)
BC Platforms AG
Congenica Ltd
FUNDACIO CENTRE DE REGULACIO GENOMICA
Phenosystems SA
Platomics GmbH
Lot 4: (Consortium Lead)
BC Platforms AG
Congenica Ltd
fragmentiX Storage Solutions GmbH
FUNDACIO CENTRE DE REGULACIO GENOMICA
Saphetor SA
Lot 2: Due to the insufficient number of tenders received, no contract was awarded in Lot 2.
Further details will be made available under Phase 1 - Solution Design
